Autonomix Medical (NASDAQ: AMIX) is a cutting-edge medical technology company developing targeted nerve therapies to revolutionize how diseases involving the peripheral nervous system are diagnosed ...
When compared with oxycodone IR in a post hoc analysis, cebranopadol demonstrated a larger magnitude of effect. Topline results were announced from a phase 3 trial evaluating cebranopadol for the ...
New longer-term post hoc analysis results of responders (n=6) 1 showed long-lasting, durable pain reduction of nearly 66%, or a mean 5.08 reduction on the VAS pain scale, in patients with severe ...
Objective: Pain is a well recognised complication of propofol injection. The purpose of this study was to compare the efficacy of flurbiprofen, lidocaine and a combination of the two in reducing pain ...
THE WOODLANDS, Texas, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (LXRX) (Nasdaq: LXRX) today announced the presentation of clinical data from the company’s Phase 2b PROGRESS ...
CARLSBAD, Calif.--(BUSINESS WIRE)--One-year data from the Nalu COMFORT randomized control trial (RCT) published in the peer-reviewed Regional Anesthesia & Pain Medicine journal confirm the consistent ...
Transvascular energy ablation showed a 79% response rate in reducing pancreatic cancer pain without opioids. Patients experienced a mean pain reduction of 4.96 points, equating to a 66% improvement in ...
With nearly a quarter of all adults experiencing chronic back pain, many Americans are now seeking alternatives to opioids for meaningful relief. A recent study, BackInAction, shows that manual ...
MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company, today announced positive topline results from its ALLEVIATE-2 Phase 3 pivotal clinical ...
The medicine for your chronic pain might be hiding in your refrigerator, not your medicine cabinet. Revolutionary research from the University of South Australia has uncovered compelling evidence that ...
A large trial showed that semaglutide, sold as Ozempic for diabetes and as Wegovy for obesity, was better than any current medications in alleviating symptoms. By Gina Kolata The blockbuster drug ...
Vertanical’s cannabis-based pain reliever, VER-01, has shown superiority over opioids in a Phase III trial. In the ELEVATE study (NCT05610813), VER-01 was pitted against opioids, prescribed at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results